Biotech · Private company · Boston, MA, US
Tigatx Inc
Track this companyFree. Adds Tigatx Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Late-stage development and de-risking of a novel monoclonal antibody immunotherapy for EGFR-positive solid cancersFiscal year 2024 · $1.4MNIH RePORTER 1R44CA291266-01 · fetched Nov 12, 2026